Register for SOSV’s HAX demo days in San Francisco (4/29) and Newark (5/6)

Kolibri

Using sound to enable advanced therapies

Team

Amélie Quilichini

CEO & Co-Founder

Gabriel Dumy

CSO & Co-Founder

Company details

Kolibri is pioneering acoustic cell engineering to radically cut the cost and complexity of therapeutic manufacturing. Our patented platform supercharges existing bioproduction workflows, achieving

  • 2x increase in AAV yields in both suspension and adherent cell systems using acoustic treatment, a promising development for scalability.
  • 5x improvement in transfection rates in mesenchymal stem cells (MSCs), raising efficiency from 7.5% to 35%.
  • 20x increase in plasmid usage efficiency, significantly reducing the potential cost per dose—an important economic lever given the high cost of plasmid reagents.

These achievements translate to a 89% lower cost per dose than current chemical methods. We’ve secured five strategic partnerships from academia to large industry player to validate the tech across real-world settings.

Get In Touch with Kolibri

Please tell us a little bit about yourself and why you'd like to get connected. Kolibri + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.